Transcatheter tricuspid valve annuloplasty for tricuspid regurgitation

Recommendation ID: IPG730/01
Question: For people with severe and symptomatic tricuspid regurgitation, evidence on the efficacy of transcatheter tricuspid valve annuloplasty is limited in quantity and quality. Evidence on its safety shows there are serious but well-recognised complications. Therefore, for these people, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE interventional procedures guidance page.
Any explanatory notes (if applicable): Further research should include details of patient selection, including the type and severity of tricuspid regurgitation.

Source guidance details

Comes from guidance: Transcatheter tricuspid valve annuloplasty for tricuspid regurgitation
Number: IPG730
Date issued: July 2022

Is this a recommendation for the use of a technology only in the context of research?	No
Is it a recommendation that suggests collection of data or the establishment of a register?	No
Last Reviewed	31/07/2022